Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors

Size: px
Start display at page:

Download "Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors"

Transcription

1 Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors David B Allison Dr. Allison has received personal payments or promises for same from: American Society for Nutrition; Biofortis; Frontiers Publishing; IKEA; Indiana University; Laura and John Arnold Foundation; Law Offices of Ronald Marron; MD Anderson Cancer Center; National Academy of Sciences; National Institutes of Health (NIH); Nestlé; Paul Hastings, LLP; Texas A&M University; The Obesity Society; Tomasik, Kotin & Kasserman LLC; University of Miami. Dr. Allison receives editorial honoraria from the American Society for Nutrition and the Obesity Society. Donations to a foundation have been made on his behalf by the Northarvest Bean Growers Association and the United Soy Bean Board. Dr. Allison is an unpaid member of the International Life Sciences Institute North America Board of Trustees. Dr. Allison s institution, Indiana University, has received funds to support his research or educational activities from: USDA; NIH; US National Science Foundation; Alliance for Potato Research and Education; Dairy Management Institute; Herbalife; Laura and John Arnold Foundation. Arne Astrup Dr. Astrup receives payment as Associate Editor of The American Journal of Clinical Nutrition and as a member of the Editorial Committee of Annual Review of Nutrition. Dr. Astrup is advisor to or a member of advisory boards for a number of food and pharmaceutical producers: Basic Research, United States; Beachbody, United States; BioCare Copenhagen, Denmark; Crossfit, United States; Dutch Beer Institute, Netherlands; Feast Kitchen A/S, Denmark; Gelesis, United States; Groupe Éthique et Santé, France; McCain Foods Limited, United States; Nestlé Research Centre, Switzerland; Novo Nordisk, Denmark; Pfizer, Germany; Saniona, Denmark; Sanofi- Aventis, Germany; S-Biotek, Denmark; Scandinavian Airlines System, Denmark; TetraPak, Sweden; Weight Watchers, United States; Zaluvida, Switzerland. Dr. Astrup does not own stock in, or have other ownership interests in, any of the companies to which he provides scientific advice, or in any nutrition company other than those companies whose stock

2 is held by various mutual fund retirement accounts. Dr. Astrup s recent research at the University of Copenhagen, Denmark, has received funding via unrestricted grants from or contracts with DC-Ingredients, Denmark; Danish Dairy Foundation; Global Dairy Platform; and Gelesis AS, United States. Dr. Astrup is the recipient of honoraria as speaker for a wide range of Danish and international concerns and receives royalties from textbooks and popular diet and cookery books. Dr. Astrup is co-inventor of a number of patents, including Methods of inducing weight loss, treating obesity and preventing weight gain (licensee Gelesis, United States) and Biomarkers for predicting degree of weight loss (licensee Nestec SA, Switzerland), owned by the University of Copenhagen, in accordance with Danish law. Dr. Astrup is co-founder and co-owner of the University of Copenhagen spin-out companies Mobile Fitness A/S, Personalized Weight Management Research Consortium ApS (Gluco-diet.dk), and Flaxslim ApS, where he is also member of the board. Dr. Astrup is not an advocate or activist for specific diets and is not strongly committed to any specific diet, e.g., veganism, Atkins diet, glutenfree diet, high animal protein diet, or dietary supplements. Dennis M Bier Dr. Bier accepts no honorarium for the work he performs as Editor-in-Chief of The American Journal of Clinical Nutrition. Dr. Bier is an advisor to the International Council on Amino Acid Science, whose members include companies that produce and market amino acids for medical, biological, and industrial purposes. Dr. Bier provides the Council with advice on scientific priorities, assistance in organizing scientific symposia on amino acids, and evaluation of competitive applications for research funding. Other than reimbursement for travel expenses, he accepts no compensation for his advisory role. In the past year, Dr. Bier has consulted for, and received honoraria from, Mallinckrodt Pharmaceuticals; Novartis Pharmaceuticals; Nestlé SA; Ajinomoto Co., Inc.; Soremartec Italia S.r.l.; the CrossFit Foundation; Intertek Scientific and Regulatory Consultancy Services; Nutritional Growth Solutions; the Dairy Management Institute;

3 and the Lorenzini Foundation. The majority of Dr. Bier s consulting fees are donated to charity. Dr. Bier does not own stock in, or have other ownership interests in, any of the companies to which he provides scientific advice or in any nutrition company other than those companies whose stock is held by various mutual fund retirement accounts. Paul M Coates Dr. Coates does not receive an honorarium from the American Society for Nutrition for his duties as Associate Editor. Naomi K Fukagawa Dr. Fukagawa receives an honorarium from the American Society for Nutrition for her duties as Associate Editor. Dr. Fukagawa serves as Director of the USDA Beltsville Human Nutrition Center. Dr. Fukagawa is the Editor-in-Chief of Nutrition Reviews. David M Klurfeld Dr. Klurfeld does not receive an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr. Klurfeld is a nutrition consultant to Dyets, Inc, a manufacturer of diets for laboratory animals. Dr. Klurfeld is a member of the American Council on Science and Health Board of Scientific and Policy Advisors whose function is to provide advice and review of statements developed by the organization. This is a noncompensated position. Simin Liu Dr. Liu reports consulting payments and honoraria or promises of the same for scientific presentations or reviews at numerous venues, including but not limited to Barilla, Johns Hopkins University, Fred Hutchinson Cancer Center, Harvard University, University of Buffalo, GuangDong General Hospital and Academy of Medical Sciences, and the National Institutes of Health. He is also a member of the Data Safety and Monitoring Board for a trial of pulmonary hypertension in diabetes patients at Massachusetts General Hospital. He receives royalties from UpToDate. Dr.

4 Liu receives an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr. Liu is listed as the lead inventor on U.S. Application Serial No. or PCT International Application No. PCT/US2009/ filed on November 16, 2009 by UCLA concerning METHODS AND COMPOSITIONS FOR PREDICTING A SUBJECT'S SUSCEPTIBILITY TO AND RISK OF DEVELOPING TYPE 2 DIABETES. Mark J Manary Dr. Manary is the Director of Project Peanut Butter, a not-for-profit focusing on improving the treatment of malnutrition as well as the production of appropriate, nutrient-dense foods. His present research activities are funded primarily by Children s Investment Fund Foundation and USAID Feed the Future program. Dr. Manary has accepted contributions of food ingredients necessary for his research work from Arla Dairy Ingredients. Dr. Manary has provided technical advice in areas of his competence on an ad-hoc basis. He does not own personal stock except for investment funds related to his pension that are not under his direct control. Dr. Manary is a member of the WHO technical expert committee on nutrition, which reviews evidence and writes draft guidelines for treatment and prevention of malnutrition worldwide. Dr. Manary does not hold or have pending patent applications related or unrelated to his research activities. Dr. Manary has spoken at meetings and conferences at the invitation of organizations representing the peanut and dairy industries, usually once a year; they have paid his travel expenses, but he has not accepted personal payments or honoraria from these organizations. Dr. Manary receives an honorarium from the American Society for Nutrition for his duties as Associate Editor. Richard Mattes Dr. Mattes receives an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr. Mattes has received travel expenses and/or honoraria for serving on scientific advisory bodies forconagra and the Grain Food Foundation and planning committees for the American Society for Nutrition, Academy for Nutrition and Dietetics, and Institute for Food Technologists. Dr. Mattes has received

5 research support and/or travel expenses from the Almond Board of California, California Walnut Commission, and Ajinomoto Co. Inc. Dr. Mattes has received travel expenses and/or honoraria for speaking at various professional meetings. Sue A Shapses Dr. Shapses receives an honorarium from the American Society for Nutrition for her duties as Associate Editor; the honorarium is used for scholarship and research purposes. Dr. Shapses, as an investigator, received research funds or consulting fees from Merck, Inc., Omni Active Tech., and Bayer, Inc. Dr. Shapses received honorarium fees and/or travel reimbursement from Johns Hopkins University, Columbia University, Wake Forest School of Medicine, and the American College of Sports Medicine. Dr. Shapses receives honorarium fees and/or travel reimbursement for consulting duties at NASA and NIH.

SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry

SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry Introduction SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry SMA Europe is an umbrella body of national Spinal Muscular Atrophy patient representative and research organisations

More information

September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board

September 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT

More information

Purpose of the summary

Purpose of the summary Summary of Expertise, Experience, and Affiliations and Interests Scientific Advisory Committee on Sciences and Clinical Pharmacology (SAC-PSCP) Purpose of the summary The following table summarizes the

More information

Yevo Scientific Advisory Board

Yevo Scientific Advisory Board TM Yevo Scientific Advisory Board Dr. Stacey J. Bell Head of the Yevo Scientific Advisory Board Dr. Stacey Bell has been a nutritional consultant from 2008 to 2014, when she joined Yevo International.

More information

Managing Conflict of Interest

Managing Conflict of Interest Managing Conflict of Interest The Challenge of Pharmaceutical Company Marketing to Medical Professionalism David J. Rothman, Ph.D. Bernard Schoenberg Professor of Social Medicine Columbia College of Physicians

More information

Biotech Concerto #6 Investment Process December 2008

Biotech Concerto #6 Investment Process December 2008 Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision

More information

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.

Other appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT. Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,

More information

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)

Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about

More information

Policy for CCG Engagement with the Pharmaceutical Industry

Policy for CCG Engagement with the Pharmaceutical Industry Policy for CCG Engagement with the Pharmaceutical Industry UNIQUE REFERENCE NUMBER: CD/MM/066/V1 DOCUMENT STATUS: DATE ISSUED: October 2014 DATE TO BE REVIEWED: October 2016 Approved by Clinical Development

More information

Form FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.

Form FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. Form 51-102FI SERNOVA CORP. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. The following discussion and analysis should be

More information

Commercialization Workshop Series Commercialization Pathways. April 2, 2015

Commercialization Workshop Series Commercialization Pathways. April 2, 2015 Commercialization Workshop Series Commercialization Pathways April 2, 2015 Commercialization Workshop Series Commercialization Pathways Commercialization Options Parasight Seikowave Dean Harvey Eric Hauck

More information

Diagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs

Diagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs Diagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs Programme Draft 10 11 May 2016 Warsaw, Poland In co-operation with: Venue Patent Office of

More information

Patent Purchase Information of Seller

Patent Purchase Information of Seller Patent Purchase Information of Seller Seller submits the following information as of November 19, 2013. 1. Contact Information. Name of company/assignee Name of seller (if different) Key contact person

More information

Merriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box Wellesley, MA

Merriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box Wellesley, MA Merriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box 812179 Wellesley, MA 02482 mpanarella@panarellaadr.com 508 653-2455 Dispute Resolution Services Dispute resolution services include

More information

Breakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC

Breakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC Breakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC Study overview Part 1: The Global Biomedical Industry: Understanding the

More information

Study overview. The Global Biomedical Industry: Preserving U.S. Leadership

Study overview. The Global Biomedical Industry: Preserving U.S. Leadership Presentation for: Voluntary Health Leadership Conference February 9, 2012 Rancho Bernardo Inn San Diego, CA Ross DeVol Chief Research Officer Milken Institute Study overview Part 1: Understanding the Factors

More information

Guidelines for Facilitating the Use of Research Tool Patents in the Life Sciences. March 1, 2007 Council for Science and Technology Policy

Guidelines for Facilitating the Use of Research Tool Patents in the Life Sciences. March 1, 2007 Council for Science and Technology Policy Guidelines for Facilitating the Use of Research Tool Patents in the Life Sciences March 1, 2007 Council for Science and Technology Policy 1. Introduction (1) In the domains of medicine and biotechnology,

More information

EL PASO COMMUNITY COLLEGE PROCEDURE

EL PASO COMMUNITY COLLEGE PROCEDURE For information, contact Institutional Effectiveness: (915) 831-6740 EL PASO COMMUNITY COLLEGE PROCEDURE 2.03.06.10 Intellectual Property APPROVED: March 10, 1988 REVISED: May 3, 2013 Year of last review:

More information

Compliance for Eucomed: The Medical Technology Industry s s Perspective

Compliance for Eucomed: The Medical Technology Industry s s Perspective Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big

More information

VTIP in 20 Minutes What You Need to Know

VTIP in 20 Minutes What You Need to Know VTIP in 20 Minutes What You Need to Know Virginia Tech Intellectual Properties, Inc. VTIP Overview Virginia Tech Intellectual Properties, Inc. Not-for-profit, affiliated corporation of Virginia Tech Aligned

More information

Smith A. Brownlie III, CPA

Smith A. Brownlie III, CPA Brownlie & Braden, LLC, provides services specifically addressing the needs of individuals and families that have accumulated significant wealth. Our approach to providing these services is sensitive to

More information

Key issues in building a strong life sciences patent portfolio. Tom Harding and Jane Wainwright Potter Clarkson LLP

Key issues in building a strong life sciences patent portfolio. Tom Harding and Jane Wainwright Potter Clarkson LLP Key issues in building a strong life sciences patent portfolio Tom Harding and Jane Wainwright Potter Clarkson LLP SECURING INNOVATION PATENTS TRADE MARKS DESIGNS Award winning, expert intellectual property

More information

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond

Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,

More information

State of Licensing 2011 Update

State of Licensing 2011 Update State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-

More information

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium

PROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data

More information

PATENT AND LICENSING POLICY SUMMARY

PATENT AND LICENSING POLICY SUMMARY PATENT AND LICENSING POLICY SUMMARY Policy II-260 OBJECTIVE To define and outline the policy of the British Columbia Cancer Agency and the British Columbia Cancer Foundation concerning the development

More information

CeQur establishes Wales subsidiary

CeQur establishes Wales subsidiary FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,

More information

ALAN G. HEVESI, : Defendant. : DEPUTY CHIEF INVESTIGATOR GREGORY J. STASIUK of the Office of

ALAN G. HEVESI, : Defendant. : DEPUTY CHIEF INVESTIGATOR GREGORY J. STASIUK of the Office of NEW YORK CITY CRIMINAL COURT NEW YORK COUNTY - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - X THE PEOPLE OF THE STATE OF NEW YORK : -against- : ALAN G. HEVESI, : FELONY COMPLAINT

More information

INTELLECTUAL PROPERTY POLICY

INTELLECTUAL PROPERTY POLICY INTELLECTUAL PROPERTY POLICY Overview The University of Texas System (UT System) Board of Regents (Board) and the University of Texas Health Science Center at San Antonio (Health Science Center) encourage

More information

TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION

TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION utrf@tennessee.com TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION Hot Topics in Research, May 23, 2017 Richard Magid, PhD UTRF Vice President WHAT IS TECHNOLOGY TRANSFER?

More information

Public Art Network Best Practice Goals and Guidelines

Public Art Network Best Practice Goals and Guidelines Public Art Network Best Practice Goals and Guidelines The Public Art Network (PAN) Council of Americans for the Arts appreciates the need to identify best practice goals and guidelines for the field. The

More information

IP and Technology Management for Universities

IP and Technology Management for Universities IP and Technology Management for Universities Yumiko Hamano Senior Program Officer WIPO University Initiative Innovation and Technology Transfer Section, Patent Division, WIPO Outline! University and IP!

More information

Connecting People, Science and Regulation

Connecting People, Science and Regulation Connecting People, Science and Regulation Bethesda Towers 4350 East West Highway Suite 600 Bethesda, MD 20814 USA Tel: +1 (301) 656-5900 Fax: +1 (301) 986-0296 www.pda.org PDA Europe ggmbh Am Borsigturm

More information

Baxter 2007 Investor Conference March 14, 2007

Baxter 2007 Investor Conference March 14, 2007 Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide

More information

Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness

Committee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness 2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities

More information

Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.

Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D. Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology

More information

Celebrating International Women's Day Friday, March 8, :30am-1:00pm

Celebrating International Women's Day Friday, March 8, :30am-1:00pm Co-Hosted by: Join us in Launching the 1st Annual Successful Women of San Diego Executive Leadership Panel Celebrating International Women's Day Friday, March 8, 2019 11:30am-1:00pm Sponsored by: Location:

More information

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences

More information

Achievements of FP7 examples that make us proud

Achievements of FP7 examples that make us proud Achievements of FP7 examples that make us proud Acknowledgements This booklet is a true, but humble, product of European cooperation, just like the inspiring examples it contains. All of the content was

More information

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division

Bayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your

More information

Financing Growth Ventures to Minimize Equity Dilution

Financing Growth Ventures to Minimize Equity Dilution Financing Growth Ventures to Minimize Equity Dilution An entrepreneurial team s mission is to develop and grow its venture and to optimize the management team s equity ownership stake. Significant growth

More information

Smith A. Brownlie III, CPA

Smith A. Brownlie III, CPA Brownlie & Braden, LLC, provides services specifically addressing the needs of individuals and families that have accumulated significant wealth. Our approach to providing these services is sensitive to

More information

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,

More information

Life Sciences Queensland announces latest LSQ Ambassadors

Life Sciences Queensland announces latest LSQ Ambassadors MEDIA RELEASE Monday 22 April, 2013 FOR IMMEDIATE RELEASE Life Sciences Queensland announces latest LSQ Ambassadors (LSQ) is pleased to announce our latest LSQ Ambassadors - two of the life sciences industry

More information

Finn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark

Finn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark EUnetHTA European network for Health Technology Assessment DATABASES, REGISTRIES AND OTHER DATA CAPTURE TOOLS: HOW CAN WE AVOID MULTIPLICITY AND CREATE AN INTEGRATED DATA-CAPTURE APPROACH ALONG THE PRODUCT

More information

THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES

THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES Join us for a very special program co-hosted the HBS Alumni of Boston (HBSAB), The Harvard Stem Cell Institute (HSCI), and the Harvard NeuroDiscovery

More information

Issues in Emerging Health Technologies Bulletin Process

Issues in Emerging Health Technologies Bulletin Process Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The

More information

Jean W. Frydman Partner

Jean W. Frydman Partner Jean W. Frydman Partner Princeton, NJ Tel: 609.895.6630 Fax: 609.896.1469 jfrydman@foxrothschild.com A former general counsel for multinational pharmaceutical companies and a multinational retail dietary

More information

Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development

Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development Richard (Rick) J. Donoghue, senior vice president for strategy, planning and business development at NYU Langone

More information

DRAFT. Cardiac Safety Research Consortium CSRC. Membership Committee Charter. 12September2018. Table of Contents

DRAFT. Cardiac Safety Research Consortium CSRC. Membership Committee Charter. 12September2018. Table of Contents DRAFT Cardiac Safety Research Consortium CSRC Membership Committee Charter 12September2018 Table of Contents Purpose of the CSRC Membership Charter and CSRC Membership Committee Composition, Responsibilities

More information

LIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)

LIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry

Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade Digital Patient Engagement Insights for the Pharmaceutical Industry March 2018 2 DIGITAL PATIENT ENGAGEMENT: INSIGHTS FOR THE PHARMACEUTICAL

More information

Management to Host Conference Call at 8:30 a.m. ET today

Management to Host Conference Call at 8:30 a.m. ET today Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),

More information

Clarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC

Clarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC Curriculum Vitae Clarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC cnelson@infact-experts.com Salt Lake City Office 175 South Main Street, Suite 630 Salt

More information

Teresa V. Pahl Partner

Teresa V. Pahl Partner Teresa represents clients in all phases and aspects of their businesses. Teresa s expertise includes matters involving general corporate law, securities law and real property law. Teresa works with early-stage

More information

Martha M. Kendrick. Areas of Experience. Practice & Background

Martha M. Kendrick. Areas of Experience. Practice & Background Martha M. Kendrick Partner mkendrick@akingump.com Washington, D.C. T +1 202.887.4215 F +1 202.887.4288 Education J.D., Georgetown University Law Center, 1985 M.A., Bowling Green State University B.A.,

More information

Ophthalmic Business Council Connecting Academy and industry leaders for more than 20 years

Ophthalmic Business Council Connecting Academy and industry leaders for more than 20 years Ophthalmic Business Council 2018 2019 Connecting Academy and industry leaders for more than 20 years Lead the conversation The Ophthalmic Business Council (OBC) is an excellent way for leaders in the ophthalmic

More information

Intellectual Property

Intellectual Property Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness

More information

First Course Lobster Bisque Soup with Roasted Fennel. Bread Service Caramelized Onion Walnut Roll with Whipped Maple Brie

First Course Lobster Bisque Soup with Roasted Fennel. Bread Service Caramelized Onion Walnut Roll with Whipped Maple Brie Innovation Wing National Museum of American History Smithsonian Institution April 14, 2016 DINNER MENU First Course Lobster Bisque Soup with Roasted Fennel Bread Service Caramelized Onion Walnut Roll with

More information

Patented Medicine Prices Review Board P M P R B GUIDELINES REFORM. 15 th Annual Market Access Summit. Douglas Clark Executive Director PMPRB

Patented Medicine Prices Review Board P M P R B GUIDELINES REFORM. 15 th Annual Market Access Summit. Douglas Clark Executive Director PMPRB Patented Medicine Prices Review Board P M P R B GUIDELINES REFORM Douglas Clark Executive Director PMPRB 15 th Annual Market Access Summit Background Canada enacted a two-fold reform of its drug patent

More information

The Global Alliance for Chronic diseases (GACD)

The Global Alliance for Chronic diseases (GACD) The Global Alliance for Chronic diseases (GACD) Global Health Policy Forum Brussels, 12 th June 2014 Karim Berkouk Deputy Head of the Medical Research Unit Health Directorate Research & Directorate General

More information

Food Science for the Non-Food Scientist Instructor Biographies

Food Science for the Non-Food Scientist Instructor Biographies Food Science for the Non-Food Scientist Instructor Biographies Bob Baron is the Vice President of Business Development at Sensory Spectrum. In this role he works closely with clients to create tailored

More information

California State University, Northridge Policy Statement on Inventions and Patents

California State University, Northridge Policy Statement on Inventions and Patents Approved by Research and Grants Committee April 20, 2001 Recommended for Adoption by Faculty Senate Executive Committee May 17, 2001 Revised to incorporate friendly amendments from Faculty Senate, September

More information

INTERNATIONAL WINTER SCHOOL

INTERNATIONAL WINTER SCHOOL INTERNATIONAL WINTER SCHOOL RESEARCH PROMOTION, TECHNOLOGY TRANSFER AND BUSINESS CREATION November 22nd 2010, Alexandria, Egypt Anita COHEN Délégation à la Recherche Clinique et à l'innovation 80 rue Brochier

More information

Science - Industry Relationships in High-tech Sectors: Transatlantic Perspectives

Science - Industry Relationships in High-tech Sectors: Transatlantic Perspectives Science - Industry Relationships in High-tech Sectors: Transatlantic Perspectives OECD / BMB+F Conference on Industry - Science Relationships Berlin, October 16-17th, 2000 no. 1 1. Empirical Basis Higher

More information

Virtual Clinical Trials: Challenges and Opportunities

Virtual Clinical Trials: Challenges and Opportunities Virtual Clinical Trials: Challenges and Opportunities November 28 29, 2018 National Academy of Sciences Building, Lecture Room 2101 Constitution Ave. NW, Washington, DC 20418 Background: The cost of bringing

More information

PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY

PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY FUNDAMENTALS OF GLOBAL LAW, PRACTICE AND STRATEGY by PHILIP W. GRUBB European Patent Attorney CLARENDON PRESS OXFORD 1999 CONTENTS Preface to the

More information

Additional information about Christopher Wootton is available on the SEC s Web site at

Additional information about Christopher Wootton is available on the SEC s Web site at Christopher Wootton ChFC CRD #5428911 Common Wealth Centre 2040 North Loop 336W, Suite 125 Conroe, TX 77304 This Brochure Supplement provides information about Christopher Wootton that supplements the

More information

Keynote speakers 2017

Keynote speakers 2017 Keynote speakers 2017 William B. Gartner Professor of Entrepreneurship and the Art of Innovation, Copenhagen Business School, Denmark and California Lutheran University, United States Keynote: All entrepreneurship

More information

Report OIE Animal Welfare Global Forum Supporting implementation of OIE Standards Paris, France, March 2018

Report OIE Animal Welfare Global Forum Supporting implementation of OIE Standards Paris, France, March 2018 Report OIE Animal Welfare Global Forum Supporting implementation of OIE Standards Paris, France, 28-29 March 2018 1. Background: In fulfilling its mandate to protect animal health and welfare, the OIE

More information

We Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations

We Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations We Work For Health Champions Awards Class of 2012 Brief Biographical Information (Alphabetical by Member Company) The We Work For Health Champion Awards are given annually to those to individuals who have

More information

Industrial Investment in Research and Development: Trends and Prospects

Industrial Investment in Research and Development: Trends and Prospects MEMO/05/471 Brussels, 9 December 2005 Industrial Investment in Research and Development: Trends and Prospects The 2005 Key Figures for science, technology and innovation released last July showed EU R&D

More information

EU Livestock subsidies' effect on red meat consumption

EU Livestock subsidies' effect on red meat consumption EU Livestock subsidies' effect on red meat consumption Nutrition, Physical Activity & Cancer Prevention: Current Challenges, New Horizons September 13, 2010 EPHAC (conflicts of interest) Brussels based

More information

To the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018

To the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018 To the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018 RECOMMENDATION OF THE NOMINATION COMMITTEE 1. INTRODUCTION The Nomination Committee of Nordic Nanovector ASA comprises of Johan Christenson

More information

Academic Technology Licensing & the America Invents Act

Academic Technology Licensing & the America Invents Act Academic Technology Licensing & the America Invents Act Eric Gosink, Ph.D. Senior Licensing Officer November 1 st, 2013 University of California San Diego Expertise and Resources Scripps Inst. Oceanography,

More information

Second medical use claims The pregabalin litigation in Europe IMK seminar at Awapatent, 18 May 2017

Second medical use claims The pregabalin litigation in Europe IMK seminar at Awapatent, 18 May 2017 Second medical use claims The pregabalin litigation in Europe IMK seminar at Awapatent, 18 May 2017 Niklas Mattsson MSc Mol Biotech Engineering European Patent Attorney niklas.mattsson@awapatent.com Outline

More information

LISA ROTH MONAHAN & ROTH, LLC 630 FIRST AVENUE SAN DIEGO, CA 92101

LISA ROTH MONAHAN & ROTH, LLC 630 FIRST AVENUE SAN DIEGO, CA 92101 LISA ROTH MONAHAN & ROTH, LLC 630 FIRST AVENUE SAN DIEGO, CA 92101 BACKGROUND Lisa Roth is the of Monahan & Roth, LLC, a regulatory compliance company providing services including professional consultations,

More information

Loyola University Maryland Provisional Policies and Procedures for Intellectual Property, Copyrights, and Patents

Loyola University Maryland Provisional Policies and Procedures for Intellectual Property, Copyrights, and Patents Loyola University Maryland Provisional Policies and Procedures for Intellectual Property, Copyrights, and Patents Approved by Loyola Conference on May 2, 2006 Introduction In the course of fulfilling the

More information

2008 HSC Notes from the Marking Centre Food Technology

2008 HSC Notes from the Marking Centre Food Technology 2008 HSC Notes from the Marking Centre Food Technology 2009 Copyright Board of Studies NSW for and on behalf of the Crown in right of the State of New South Wales. This document contains Material prepared

More information

Shareholders are invited to the 2018 Annual Meeting which is scheduled for 27 September 2018.

Shareholders are invited to the 2018 Annual Meeting which is scheduled for 27 September 2018. 7 September 2018 Dear Shareholder 2018 Annual Meeting of Shareholders Shareholders are invited to the 2018 Annual Meeting which is scheduled for 27 September 2018. The details of the Annual Meeting are

More information

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)

THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID

More information

2016 ICGN Annual General Meeting

2016 ICGN Annual General Meeting Item 14, June ICGN Board Meeting 2016 ICGN Annual General Meeting Composition of the Nomination Committee Erik Breen, Chair, ICGN Board of Governors The ICGN Nomination Committee is constituted in accordance

More information

How To Draft Patents For Future Portfolio Growth

How To Draft Patents For Future Portfolio Growth For the latest breaking news and analysis on intellectual property legal issues, visit Law today. www.law.com/ip Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law.com Phone: +1 646

More information

Size of California s economy US$ trillions, 2009

Size of California s economy US$ trillions, 2009 Size of California s economy US$ trillions, 2009 Rank Country Gross domestic product 1 United States 14 2 Japan 5.1 3 China 4.9 4 Germany 3.3 5 France 2.6 6 United Kingdom 2.2 7 44 Italy 2.1 8 California

More information

South-South Exchange Meeting on the Conservation and Sustainable Use of Forest Biodiversity, 8-10 July 2009

South-South Exchange Meeting on the Conservation and Sustainable Use of Forest Biodiversity, 8-10 July 2009 South-South Exchange Meeting on the Conservation and Sustainable Use of Forest Biodiversity, 8-10 July 2009 ACCESS TO GENETIC RESOURCES AND BENEFIT-SHARING Valérie Normand Secretariat of the Convention

More information

Sofosbuvir Patent Oppositions at European Patent Office

Sofosbuvir Patent Oppositions at European Patent Office Challenging patent system in High Income Countries Sofosbuvir Patent Oppositions at European Patent Office Olivier Maguet Médecins du Monde, Drug Pricing Campaign WHS 2017, Sao Paulo, Options for countries

More information

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as: HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually

More information

150th Annual General Meeting of Nestlé S.A. Lausanne, 6 April Speeches. Peter Brabeck-Letmathe Chairman of the Board

150th Annual General Meeting of Nestlé S.A. Lausanne, 6 April Speeches. Peter Brabeck-Letmathe Chairman of the Board 150th Annual General Meeting of Nestlé S.A. Lausanne, 6 April 2017 Speeches Peter Brabeck-Letmathe Chairman of the Board Ulf Mark Schneider Chief Executive Officer Disclaimer This speech might not reflect

More information

PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS

PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS PRESS RELEASE FOR IMMEDIATE RELEASE PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS US $80 million (CAD $100 million) line of credit secured from Structured Alpha LP Plasminogen BLA

More information

The 2011 EU industrial R&D investment SCOREBOARD

The 2011 EU industrial R&D investment SCOREBOARD 1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at

More information

WIPO NATIONAL WORKSHOP FOR PATENT LAWYERS

WIPO NATIONAL WORKSHOP FOR PATENT LAWYERS ORIGINAL: English DATE: May 1997 GOVERNMENT OF THE FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA WORLD INTELLECTUAL PROPERTY ORGANIZATION WIPO NATIONAL WORKSHOP FOR PATENT LAWYERS organized by the World Intellectual

More information

Eligibility Criteria Created Sunday, November 09, 2014

Eligibility Criteria Created Sunday, November 09, 2014 Eligibility Criteria Created Sunday, November 09, 2014 Please review each eligibility criteria below. Please check the box if you are in compliance with each criteria. Ineligible applicants will not be

More information

INTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima

INTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima INTELLECTUAL PROPERTY OVERVIEW Patrícia Lima October 14 th, 2015 Intellectual Property INDUSTRIAL PROPERTY (INPI) COPYRIGHT (IGAC) It protects technical and aesthetical creations, and trade distinctive

More information

Meeting of the EDEN HEALTH DISTRICT BOARD OF DIRECTORS OPEN SESSION January 16, 2019 Eden Health District - Conference Room. 5:30 p.m.

Meeting of the EDEN HEALTH DISTRICT BOARD OF DIRECTORS OPEN SESSION January 16, 2019 Eden Health District - Conference Room. 5:30 p.m. Meeting of the EDEN HEALTH DISTRICT BOARD OF DIRECTORS OPEN SESSION - Conference Room. 5:30 p.m. APPROVED I. CALL TO ORDER Chair Galvan called the meeting to order at 5:30 p.m. Directors Present: Staff

More information

[Definitions of terms that are underlined are found at the end of this document.]

[Definitions of terms that are underlined are found at the end of this document.] Policy Direction - Pharmaceutical Industry Relationships [Definitions of terms that are underlined are found at the end of this document.] Rationale and Relationship to Mission, Principles and Values The

More information

Transferring UCLA discoveries to the public. Kathryn Atchison, DDS, MPH Vice Provost, Associate Vice Chancellor for Research

Transferring UCLA discoveries to the public. Kathryn Atchison, DDS, MPH Vice Provost, Associate Vice Chancellor for Research Transferring UCLA discoveries to the public. Kathryn Atchison, DDS, MPH Vice Provost, Associate Vice Chancellor for Research UCLA Research: A Winning Environment $811M+ in research awards for FY2006 3,300

More information

THE EUROPEAN COUNCIL OF ACADEMIES OF APPLIED SCIENCES, TECHNOLOGIES AND ENGINEERING

THE EUROPEAN COUNCIL OF ACADEMIES OF APPLIED SCIENCES, TECHNOLOGIES AND ENGINEERING THE EUROPEAN COUNCIL OF ACADEMIES OF APPLIED SCIENCES, TECHNOLOGIES AND ENGINEERING Presentation to the CAETS Council Meeting Beijing, June 4, 2014 Jacques Lukasik, Euro-CASE Secretary General Fellow of

More information

Implementation of Systems Medicine across Europe

Implementation of Systems Medicine across Europe THE CASyM ROADMAP Implementation of Systems Medicine across Europe A short roadmap guide 0 The road toward Systems Medicine A new paradigm for medical research and practice There has been a data generation

More information

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM

DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar

More information

SPONSORED BY WORLD GOLD TRUST SERVICES, LLC

SPONSORED BY WORLD GOLD TRUST SERVICES, LLC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information